KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Return on Equity (2020 - 2025)

Historic Return on Equity for GoodRx Holdings (GDRX) over the last 6 years, with Q3 2025 value amounting to 0.05%.

  • GoodRx Holdings' Return on Equity rose 700.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 700.0%. This contributed to the annual value of 0.02% for FY2024, which is 300.0% up from last year.
  • Per GoodRx Holdings' latest filing, its Return on Equity stood at 0.05% for Q3 2025, which was up 700.0% from 0.05% recorded in Q2 2025.
  • GoodRx Holdings' 5-year Return on Equity high stood at 0.05% for Q2 2025, and its period low was 0.44% during Q1 2021.
  • Moreover, its 5-year median value for Return on Equity was 0.02% (2024), whereas its average is 0.07%.
  • Per our database at Business Quant, GoodRx Holdings' Return on Equity plummeted by -3200bps in 2021 and then skyrocketed by 4200bps in 2022.
  • GoodRx Holdings' Return on Equity (Quarter) stood at 0.03% in 2021, then plummeted by -36bps to 0.04% in 2022, then surged by 74bps to 0.01% in 2023, then skyrocketed by 314bps to 0.02% in 2024, then skyrocketed by 121bps to 0.05% in 2025.
  • Its last three reported values are 0.05% in Q3 2025, 0.05% for Q2 2025, and 0.04% during Q1 2025.